Autonomic Neuropathy, Diabetic
4
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
20 treatments under study, led by Force Plate Platform
Research Leaders
6 sponsors active, led by Aalborg University Hospital
Related Conditions
Often studied with 17 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Diabetes, Falls, and Fractures
Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes
Research Network
Common Treatments
- Force Plate Platform2
- Handgrip Strength2
- Composite Autonomic Symptom Score 312
- Biospecimen Collection1
- Dapagliflozin1
Active Sponsors
- Aalborg University Hospital2
- Aalborg University1
- Novo Nordisk A/S1
- Glostrup University Hospital, Copenhagen1
- Steno Diabetes Center Copenhagen1
Top Investigators
HU/UFSC
Related Conditions
- Diabetes Mellitus Type 11
- Small Fiber Neuropathy1
- Diabetic Neuropathy Peripheral1
- Diabetic Peripheral Neuropathy1
- Muscle Weakness1